Measurement of Daily Defined Doses of Fluoroquinolones: A Start to Improving Antimicrobial Stewardship in Pennsylvania Hospitals

      BACKGROUND: Many national guidelines and references have been developed for the reduction of Clostridium difficile Infection (CDI) and establishing and/or improving antimicrobial stewardship. Outcome measures were readily available through the National Healthcare Safety Network (NHSN) to demonstrate improvement in CDI. However, there were no national recommended measures or data bases for tracking improvement in antibiotic usage. For our work, it was decided that daily defined doses (DDD) of fluoroquinolones would be used as a measure to show improvement in hospitals' antibiotic stewardship programs (ASP) in this association's collaborative.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect